Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingfei Wu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2020
Wavelength-Tunable Mid-Infrared Lasing from Black Phosphorus NanosheetsYushuang Zhang, Shaowei Wang, Shula Chen, et al.
Journal of the American Chemical Society|January 10, 2026
Stability and Degradation-based Proteome Profiling Reveals Cannabidiol as a Promising CDC123-eIF2γ Inhibitor for Colorectal Cancer TherapyHengyuan Yu, Yang Chen, Mingfei Wu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
PARylation promotes acute kidney injury <i>via</i> RACK1 dimerization-mediated HIF-1<i>α</i> degradationXiangyu Li, Xiaoyu Shen, Xinfei Mao, et al.
Nanoscale|October 19, 2019
Large-area, lithography-free, narrow-band and highly directional thermal emitterXingxing Liu, Zhiwei Li, Zhengji Wen, et al.
Bioorganic Chemistry|November 12, 2023
Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancerYiquan Wu, Mingfei Wu, Xiaoli Zheng, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic functionYuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Journal of Medicinal Chemistry|January 4, 2025
Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTACJiexuan Chen, Mingfei Wu, Jun Mo, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Advanced Materials (Deerfield Beach, Fla.)|March 12, 2020
Wavelength-Tunable Mid-Infrared Lasing from Black Phosphorus NanosheetsYushuang Zhang, Shaowei Wang, Shula Chen, et al.
Journal of the American Chemical Society|January 10, 2026
Stability and Degradation-based Proteome Profiling Reveals Cannabidiol as a Promising CDC123-eIF2γ Inhibitor for Colorectal Cancer TherapyHengyuan Yu, Yang Chen, Mingfei Wu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
PARylation promotes acute kidney injury <i>via</i> RACK1 dimerization-mediated HIF-1<i>α</i> degradationXiangyu Li, Xiaoyu Shen, Xinfei Mao, et al.
Nanoscale|October 19, 2019
Large-area, lithography-free, narrow-band and highly directional thermal emitterXingxing Liu, Zhiwei Li, Zhengji Wen, et al.
Bioorganic Chemistry|November 12, 2023
Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancerYiquan Wu, Mingfei Wu, Xiaoli Zheng, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic functionYuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Journal of Medicinal Chemistry|January 4, 2025
Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTACJiexuan Chen, Mingfei Wu, Jun Mo, et al.
Pageof 5